A new clinical trial is studying whether a combination of two immunotherapy drugs -botensilimab and balstilimab- can help people with advanced microsatellite stable (MSS) colorectal cancer live longer and improve their quality of life. This study is for people whose colorectal cancer: Is MSS Cannot be removed by surgery Has progressed after all currently ...
January 2026 Some individuals with metastatic colorectal cancer have a specific genetic change called BRAF V600E. This mutation is linked to faster-growing cancer and has traditionally been harder to treat. Researchers are working to find better first-line (initial) treatment options for this group of patients. The study New findings from the BREAKWATER ...
January 2026 Results from the International ColoCare Study were presented at this year's ASCO GI Symposium and found that greater levels of physical activity in the first 2 years after a colorectal cancer (CRC) diagnosis were linked to reduced cancer-related fatigue and improved quality of life in patients with non-metastatic CRC. ...
January 2026 A French study published in The BMJ found that higher intake of food preservatives, additives that are used in industrially processed foods and drinks to extend their shelf life, is linked to a modest increase in the risk of developing cancer. The study While some experimental studies have shown that some preservatives can have a ...
A new study published in the Journal of the American Medical Association looked at cancer deaths in people younger than 50 in the U.S. from 1990 to 2023 to see whether outcomes are improving. Overall, cancer death rates in this age group have dropped by 44% over the past 30 years. Deaths from many major ...
It's Sunday morning, January 11th, 2026 and where do I start? I'm sitting here reflecting on the loss of my darling son Russell. He was taken from us two and a half years ago at the age of 38. As parents, there's an emptiness in our hearts that can never ...
A recent Italian phase II clinical trial (NO-CUT), published in The Lancet Oncology, evaluated whether some patients with stage II–III rectal cancer can safely avoid surgery after responding completely to upfront treatment. The study focused on patients with a common tumor subtype known as pMMR/MSS. pMMR/MSS: proficient mismatch repair / microsatellite stable, describes a "normal" state in cancer cells, especially colorectal ...
A new study - the ATOMIC trial - has found that adding the immunotherapy atezolizumab to standard chemotherapy (FOLFOX) significantly improves outcomes for people with stage III deficient DNA mismatch repair (dMMR) colon tumours - a type of cancer that makes up about 10–15% of non-metastatic colorectal cancers. Key Findings 50% lower risk of cancer recurrence or ...
November 2025 A new study published in JAMA Oncology found that women who eat more ultraprocessed foods (UPFs) such as packaged snacks, sugary drinks, and processed meats may have a higher risk of developing early precancerous growths in the colon. The study followed over 29,000 female nurses under age 50 for more than two decades. Researchers ...
November 2025 New research from the microONE project (CBmed GmbH, Austria) suggests that microplastics may impact gut health by altering the microbiome. Using human stool samples to create controlled gut cultures, researchers exposed the samples to five common microplastics - polystyrene, polypropylene, low-density polyethylene, poly(methyl methacrylate), and polyethylene terephthalate - ...
1 Westmount Square, Suite 1630
Westmount, QC H3Z 2P9
Canada
info@colorectalcancercanada.com
© Colorectal Cancer Canada All rights reserved
Charitable registration number 86657 2423 RR0001
